Mirae Asset Global Etfs Holdings Ltd. Alkermes Plc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Alkermes Plc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 102,885 shares of ALKS stock, worth $3.2 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
102,885
Previous 100,032
2.85%
Holding current value
$3.2 Million
Previous $2.88 Million
18.12%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding ALKS
# of Institutions
410Shares Held
177MCall Options Held
229KPut Options Held
436K-
Black Rock Inc. New York, NY29.1MShares$906 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$567 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$367 Million0.05% of portfolio
-
State Street Corp Boston, MA8.02MShares$250 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.88MShares$214 Million3.72% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.11B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...